DK0821680T3 - Nye taxoider, fremstilling af disse forbindelser og farmaceutiske præparater indeholdende disse forbindelser - Google Patents

Nye taxoider, fremstilling af disse forbindelser og farmaceutiske præparater indeholdende disse forbindelser

Info

Publication number
DK0821680T3
DK0821680T3 DK96911009T DK96911009T DK0821680T3 DK 0821680 T3 DK0821680 T3 DK 0821680T3 DK 96911009 T DK96911009 T DK 96911009T DK 96911009 T DK96911009 T DK 96911009T DK 0821680 T3 DK0821680 T3 DK 0821680T3
Authority
DK
Denmark
Prior art keywords
compounds
preparation
pharmaceutical compositions
compositions containing
new taxoids
Prior art date
Application number
DK96911009T
Other languages
English (en)
Inventor
Herve Bouchard
Jean-Dominique Bourzat
Alain Commercon
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK0821680T3 publication Critical patent/DK0821680T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK96911009T 1995-04-03 1996-04-01 Nye taxoider, fremstilling af disse forbindelser og farmaceutiske præparater indeholdende disse forbindelser DK0821680T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9503868A FR2732342B1 (fr) 1995-04-03 1995-04-03 Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
PCT/FR1996/000487 WO1996031493A1 (fr) 1995-04-03 1996-04-01 Nouveaux taxoïdes, leur preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
DK0821680T3 true DK0821680T3 (da) 2000-11-20

Family

ID=9477663

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96911009T DK0821680T3 (da) 1995-04-03 1996-04-01 Nye taxoider, fremstilling af disse forbindelser og farmaceutiske præparater indeholdende disse forbindelser

Country Status (32)

Country Link
US (1) US5959125A (da)
EP (1) EP0821680B1 (da)
JP (1) JPH11504004A (da)
KR (1) KR19980703520A (da)
CN (1) CN1073106C (da)
AP (1) AP784A (da)
AR (1) AR002730A1 (da)
AT (1) ATE195940T1 (da)
AU (1) AU703918B2 (da)
BG (1) BG62964B1 (da)
BR (1) BR9604799A (da)
CA (1) CA2214322C (da)
CZ (1) CZ287430B6 (da)
DE (1) DE69610085T2 (da)
DK (1) DK0821680T3 (da)
EA (1) EA000726B1 (da)
ES (1) ES2151155T3 (da)
FR (1) FR2732342B1 (da)
GE (1) GEP19991872B (da)
GR (1) GR3034203T3 (da)
HU (1) HUP9802042A3 (da)
IL (1) IL117760A (da)
MX (1) MX9707427A (da)
NO (1) NO974563L (da)
NZ (1) NZ305898A (da)
PL (1) PL322581A1 (da)
PT (1) PT821680E (da)
RO (1) RO115879B1 (da)
SK (1) SK282047B6 (da)
TW (1) TW347389B (da)
WO (1) WO1996031493A1 (da)
ZA (1) ZA962633B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6495579B1 (en) 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
FR2764118B1 (fr) * 1997-05-30 2000-08-04 Thomson Csf Transistor bipolaire stabilise avec elements isolants electriques
US6156789A (en) * 1998-03-17 2000-12-05 Rhone-Poulenc Rorer S.A. Method for treating abnormal cell proliferation in the brain
CA2365776A1 (en) * 1999-05-03 2000-11-09 Alain Renard Method for treating abnormal cell proliferation in the brain
MXPA01009921A (es) * 2000-02-02 2003-08-01 Univ Florida State Res Found Taxanos sustituidos como carbamoiloxilo en c10 como agentes antitumorales.
US6649632B2 (en) 2000-02-02 2003-11-18 Fsu Research Foundation, Inc. C10 ester substituted taxanes
PL350028A1 (en) * 2000-02-02 2002-10-21 Univ Florida State Res Found C10 carbonate substituted taxanes as antitumor agents
JP2004339475A (ja) * 2003-02-03 2004-12-02 Merck Patent Gmbh フッ化物、オキシフッ化物、フルオロ硫化物および/またはオキシフルオロ硫化物に基づく真珠光沢顔料
EP1663153A4 (en) * 2003-05-20 2011-01-05 Aronex Pharmaceuticals Inc COMBINATION SCHEMOTHERAPY WITH A LIPOSOMAL PLATINUM COMPLEX
SV2006002010A (es) 2004-02-13 2006-08-23 Univ Florida State Res Found Taxanos sustituidos con esteres de ciclopentilo en c10
MX2007009748A (es) * 2005-02-14 2007-09-26 Univ Florida State Res Found Composiciones de taxano sustituidas con esteres ciclopropilicos en c10.
EP2276755A4 (en) * 2008-03-31 2011-05-04 Univ Florida State Res Found C (10) -ETHYESTER- AND C (10) -CYCLOPROPYLESTER-SUBSTITUTED TAXANES

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5254580A (en) * 1993-01-19 1993-10-19 Bristol-Myers Squibb Company 7,8-cyclopropataxanes
DE69333339T2 (de) * 1992-07-01 2004-09-23 Bristol-Myers Squibb Co. 7,8-Zyclopropataxane mit Antitumorwirkung
FR2698871B1 (fr) * 1992-12-09 1995-02-24 Rhone Poulenc Rorer Sa Nouveau taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
IL107950A (en) * 1992-12-15 2001-04-30 Upjohn Co 7β, 8β - METHANO-TAXOLS, THEIR PREPARATION AND ANTINEOPLASTIC PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
HUP9802042A3 (en) 2001-02-28
AU5402896A (en) 1996-10-23
CA2214322A1 (fr) 1996-10-10
IL117760A0 (en) 1996-08-04
AU703918B2 (en) 1999-04-01
PL322581A1 (en) 1998-02-02
BG62964B1 (bg) 2000-12-29
EA199700288A1 (ru) 1998-04-30
SK282047B6 (sk) 2001-10-08
US5959125A (en) 1999-09-28
NO974563D0 (no) 1997-10-02
GEP19991872B (en) 1999-12-06
GR3034203T3 (en) 2000-11-30
CA2214322C (fr) 2007-01-30
FR2732342A1 (fr) 1996-10-04
IL117760A (en) 2001-11-25
KR19980703520A (ko) 1998-11-05
CZ310997A3 (cs) 1998-01-14
AP784A (en) 1999-11-22
BG101940A (en) 1998-11-30
ES2151155T3 (es) 2000-12-16
TW347389B (en) 1998-12-11
AP9701094A0 (en) 1997-10-31
HUP9802042A2 (hu) 2000-06-28
DE69610085T2 (de) 2001-01-11
CN1179777A (zh) 1998-04-22
MX9707427A (es) 1998-02-28
AR002730A1 (es) 1998-04-29
ATE195940T1 (de) 2000-09-15
FR2732342B1 (fr) 1997-04-30
JPH11504004A (ja) 1999-04-06
WO1996031493A1 (fr) 1996-10-10
EP0821680A1 (fr) 1998-02-04
PT821680E (pt) 2000-12-29
DE69610085D1 (de) 2000-10-05
CN1073106C (zh) 2001-10-17
NO974563L (no) 1997-11-24
BR9604799A (pt) 1999-04-06
EP0821680B1 (fr) 2000-08-30
ZA962633B (en) 1996-10-07
NZ305898A (en) 1998-12-23
CZ287430B6 (en) 2000-11-15
EA000726B1 (ru) 2000-02-28
SK133397A3 (en) 1998-02-04
RO115879B1 (ro) 2000-07-28

Similar Documents

Publication Publication Date Title
DK0817780T3 (da) Taxoider, fremstilling af disse forbindelser og farmaceutiske præparater indeholdende disse forbindelser
DK0876362T3 (da) Nye taxoider, deres fremstilling og farmaceutiske præparater deraf
NO955034D0 (no) Nye substituerte 1H-imidazoler og farmasöytiske preparater inneholdende disse
DK1156049T3 (da) Substituerede heterocykliske forbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
CY2005007I2 (el) Φαρμακευτικες συνθεσεις που περιεχουν δαριφενακινη
FI973039A0 (fi) Uusia farnesyylitransferaasin inhibiittoreita, niiden valmistus ja niitä sisältäviä farmaseuttisia koostumuksia
FI973279A7 (fi) Uudet farnesyylitransferaasin inhibiittorit, niiden valmistus ja niitä sisältävät farmaseuttiset koostumukset
DK0747050T3 (da) Farmaceutiske sammensætninger indeholdende irbesartan
NO975987D0 (no) 4-Fenylaminotiazol-derivater, fremgangsmåte for fremstilling av disse og farmasöytiske blandinger inneholdende nevnte derivater
DK0885204T3 (da) Nye arylglycinamidderivater, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende disse forbindelser
DK0847391T3 (da) Aromatiske forbindelse og farmaceutiske præparater indeholdende disse
DK0973763T3 (da) Hidtil ukendte 2-(iminomethyl)aminophenylderivater, fremstilling af disse, anvendelse af disse i egenskab af lægemidler og farmaceutiske præparater indeholdende disse
DK0885208T3 (da) Taxoider, fremstilling af disse forbindelser og farmaceutiske præparater indeholdende disse forbindelser
DK0820448T3 (da) Nye taxoider, deres fremstilling og farmaceutiske præparater deraf
NO992998L (no) Nye analoger av camptotecin, anvendelse som medikamenter og farmasöytiske blandinger som inneholder disse
DK102990D0 (da) Thieno-triazolodiazepinderivater, fremgangsmaade til fremstilling af saadanne forbindelser og laegemiddel indeholdende disse
DK0805806T3 (da) Fremgangsmåde til fremstilling af 4,10-diacetoxy-2alpha-benzoyloxy-5beta,20-epoxy-1,7beta-dihydroxy-9-oxotax-11-en-13alpha-
GR3034203T3 (en) Novel taxoids, preparation thereof, and pharmaceutical compositions containing same
FI964900A0 (fi) Uudet taksoidit, niiden valmistus ja niitä sisältävät farmaseuttiset valmisteet
FI951091A7 (fi) Uudet alkyyliaminoindaaniyhdisteet, menetelmät niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
DK0831820T3 (da) Oral farmaceutisk sammensætning af piperidinoalkanolforbindelser på opløsningsform
DK0874838T3 (da) Nye taxoider, fremstilling af disse og farmaceutiske præparater indeholdende disse
MX9203732A (es) R-enentiomeros de compuestos de n-propargil-1-aminoindan, su preparacion y composiciones farmaceuticas que contienen los mismos.
NO942181D0 (no) Nye, substituerte oksazinoisokinolinderivater, farmasöytiske preparater inneholdende disse og fremgangsmåte for fremstilling av disse
NO991481L (no) Nye heteroaryloksyetylaminer, fremgangsmÕte for fremstilling av, anvendelse som medisin og farmas°ytiske blandinger inneholdende disse